The Board has determined that additional development is needed to determine if the veteran's immune complex disease, including chloracne, acute and subacute peripheral neuropathy, porphyria cutanea tarda, or any other immune complex disease are at least as likely as not directly related to his exposure to Agent Orange in service.
The deciding factor: The medical evidence is unclear regarding whether the veteran has any present immune complex disease associated with his service in Vietnam and if these conditions are related to his exposure to Agent Orange.
- Claimed conditions
- immune complex disease, chloracne, acute and subacute peripheral neuropathy, porphyria cutanea tarda
- How they argued it
- Presumptive (no nexus needed)
- Exposure basis
- Agent Orange / herbicides
- Rating assigned
- None in this decision
- Decision date
- December 9, 2008
- Citation
- 0842329
This is a plain-language summary generated by AI from a public Board of Veterans’ Appeals decision. It can contain errors — always verify against the original. Look up the original decision on VA.gov (opens in a new tab) using citation 0842329.
What this means for you
A remand is not a loss. The Board sent the case back for more development — often a new exam or missing records — before making a final decision. Many remands later end in a grant, and the decision spells out exactly what the Board wanted to see.
What you can do next
Related decisions
Other Board decisions on a similar condition or argued the same way.
- Remanded (sent back)
The Veteran's spouse is seeking to be substituted as the appellant for claims of service connection filed by the Veteran in August 2017. The AOJ has not yet determined whether she meets the requirements to substitute, and this issue must be remanded.
- Granted
The Veteran's chloracne is presumed to be caused by his exposure to herbicide agents during service, and the Board has granted service connection for this condition.
- Granted
The Board has granted the Veteran's claim for service connection for porphyria cutanea tarda, finding that it manifested within one year of his exposure to herbicides in Vietnam. The appeal is granted.
- Denied
The Veteran's claim for an initial disability rating in excess of 10 percent for chloracne with pilonidal cyst associated with TERA participation was denied, and the claim for an effective date prior to July 29, 2024, for service connection was also denied.
Free starter guide for your own claim
Reading this because you were denied or under-rated? Get the plain-English next steps — your appeal options, the deadline that protects you, and how appeals like yours turn out. One email, no spam.
We will only use this to send the guide. No spam, unsubscribe any time. We never sell your information.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.